Description

Dorzitim (dorzolamide, timolol) Eye Drops Solution 5 ml Vial Cap

Ingredients:

Each ml contains dorzolamide hydrochloride 20 mg and timolol maleate 5 mg.

Dosage:

Instill 1 drop in the affected eye(s) twice a day.

Indications:

Dorzitim eye drops are indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications:

Do not use Dorzitim if you are allergic to dorzolamide, timolol, or any other ingredients in the product.

Directions:

Shake well before use. Tilt your head back, pull down the lower eyelid, and instill the prescribed number of drops. Close your eye for 1-2 minutes without blinking.

Scientific Evidence:

Dorzitim combines the actions of dorzolamide, a carbonic anhydrase inhibitor, and timolol, a non-selective beta-adrenergic antagonist, to reduce intraocular pressure. Dorzolamide decreases aqueous humor production, while timolol reduces its secretion. Clinical studies have shown that the combination of these two agents provides effective and sustained reduction in intraocular pressure.

Additional Information:

It is important to adhere to the prescribed dosage and frequency of Dorzitim to achieve optimal therapeutic effects. Contact your healthcare provider if you experience any eye irritation, vision changes, or other unexpected side effects while using this medication.

Research has demonstrated the efficacy of dorzolamide and timolol in lowering intraocular pressure and managing glaucoma. A study published in the Journal of Ocular Pharmacology and Therapeutics found that the combination of dorzolamide and timolol was well-tolerated and effective in reducing intraocular pressure in patients with glaucoma.